# Dusquetide for the Treatment of Behcet's Disease

> **NCT06386744** · PHASE2 · COMPLETED · sponsor: **Soligenix** · enrollment: 8 (actual)

## Conditions studied

- Behçet Disease

## Interventions

- **DRUG:** Dusquetide

## Key facts

- **NCT ID:** NCT06386744
- **Lead sponsor:** Soligenix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-18
- **Primary completion:** 2025-05-23
- **Final completion:** 2025-06-17
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386744, "Dusquetide for the Treatment of Behcet's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06386744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*